Contents
Download PDF
pdf Download XML
153 Views
17 Downloads
Share this article
Research Article | Volume 14 Issue 5 (Sept - Oct, 2024) | Pages 735 - 743
Study Of Reperfusion Arrhythmias in Post- Thrombolytic Therapy in Acute Myocardial Infarction
 ,
 ,
 ,
1
Associate Professor, Department of General Medicine, NRI Institute of Medical Sciences, Visakhapatnam, Andhra Pradesh, India
2
Assistant Professor, Department of General Medicine, NRI Institute of Medical Sciences, Visakhapatnam, Andhra Pradesh, India.
3
Post Graduate, Department of General Medicine, NRI Institute of Medical Sciences, Visakhapatnam, Andhra Pradesh, India.
Under a Creative Commons license
Open Access
Received
Sept. 7, 2024
Revised
Sept. 20, 2024
Accepted
Oct. 8, 2024
Published
Oct. 29, 2024
Abstract

According to the present statistics, end of this decade the non-communicable disease will cause 70% of deaths in developing countries. The use of thrombolytic strategies like Streptokinase has been reason for reduction in mortality and Reperfusion arrhythmias have been considered successful markers of reperfusion. The prevalence of reperfusion arrhythmias during and within 48 hours of intravenous streptokinase therapy, to assess the prognosis of myocardial infarction (MI) secondary to thrombolytic therapy, and find if the reperfusion arrhythmias are non-invasive markers of successful thrombolysis using the electrocardiogram. Methodology: 100 Patients admitted to NRI Institute of Medical Sciences, Sangivalsa, tertiary care, teaching hospital in South India, with features suggestive of acute myocardial infarction who have undergone thrombolytic therapy are selected for the study. These 100 patients were divided into 5 age groups as 35-45,46-55, 56-65,66-75 and 76-85years. Each age group was further divided into male and female groups. Adult patients of both sexes and different age groups after obtaining formal consent from the patients or relatives were included. Reperfusion arrhythmias during and within 48 hours of thrombolytic therapy using electrocardiography (ECG) were assessed. Results: Among all types of myocardial infractions (MI), Reperfusion Arrhythmias are more prevalent in anterior wall MI (43%) and less observed in inferoposterior wall MI (7%). The prevalence of the age and sex has been depicted. Maximum incidence of reperfusion arrhythmias was present in age group of 46-55 years i.e 28% followed by 66-75 i.e 26%,56-65-16%,35-45 and 76-85-15%. Among males and females, 57% of males and 43% of females showed maximum incidence. Results showed that there was no significant relationship between age and gender with reperfusion arrhythmias.  There was a significant relationship observed between reperfusion arrhythmias and Diabetes (p=0.023). Incidence with hypertension (HTN) was 53%, and although hypertension was high in MI, the p-value was not significant between reperfusion arrhythmias and hypertension. Reperfusion arrhythmias incidence in risk factors such as alcoholics and smokers which was not significant, suggests that there was no statistical significance between these risk factors and arrhythmias. Observations drawn from results suggest that window period hospital presentation and types of myocardial infarction do not influence the occurrence of reperfusion arrhythmias (P=0.778) and there was a significant relation between reperfusion arrhythmias and survival of the effected patients of the study group (p=0.014).

Conclusion:

  • Arrhythmias are most frequently seen during or following thrombolysis of Acute MI. Mortality and morbidity of Acute MI can be modified by early recognition and management of these arrhythmias.
  • Acute MI is a major cause of hospitalization in the elderly and is associated with higher mortality and morbidity, most frequently seen between the 4th to 7th decades, with male preponderance.
  • Mortality was high in Anterior wall MI, Ant Inf wall MI, which were associated with Ventricular Tachycardia, Ventricular Fibrillation, showing 100% mortality which must be intervened immediately.
  • Reperfusion Arrhythmias are not an event of serious concern as they are usually well-tolerated and are amenable to treatment. Early streptokinase therapy has a favorable impact on mortality in MI and hence should be tried in all the Acute MI patients who do not have contraindications for streptokinase therapy.
Keywords
INTRODUCTION

At beginning of the third millennium, the prevalence of non-communicable diseases is rising across the globe. According to the present statistics, end of this decade the non-communicable disease will cause 70% of deaths in developing countries. The major non-communicable diseases that are usually seen are cardiovascular diseases (ischemic heart disease-IHD and hypertension), diabetes, cancer, and chronic pulmonary disease.1-3 Burden of these conditions affects countries worldwide but with a growing trend in developing countries. Diabetes and hypertension, apart from other disabilities, can lead to IHD. Its is the most common, serious, chronic, life-threatening illness in the United States, where 13 million persons have IHD of which >6 million have angina pectoris, and >7 million have sustained myocardial infarction.4

 

These conditions are also a major cause of mortality and morbidity in the Asia-Pacific region and account for around half of the global burden i.e., around seven million deaths and 129 million disability-adjusted life years (DALYs) annually from 1990 to 2010 according to World Health Organization (WHO) records.5-9 The epidemiologic characteristics of acute myocardial infarction (AMI) have changed dramatically over the past three to four decades. Since 1987, the adjusted incidence rate of hospitalization for acute myocardial infarction or fatal coronary artery disease in the United States has declined by 4 to 5% per year.10,11 Nevertheless, approximately 5,50,000 first episodes and 2,00,000 recurrent episodes of acute myocardial infarction occur annually. Globally, ischemic heart disease has become the leading contributor to the burden of disease as assessed based on disability-adjusted life years.12

 

The use of thrombolytic strategies like Streptokinase has been prevalent for decades, and there was a significant reduction in mortality after the thrombolytic therapy. Reperfusion arrhythmias have been considered successful markers of reperfusion. Many studies regarding the consideration of reperfusion arrhythmias as a marker of reperfusion have been going on for decades. So, the main aim of this study is to see whether reperfusion arrhythmias can be considered prognostic indicators for thrombolysis or not.

 

Thus, this study aims to know the prevalence of reperfusion arrhythmias during and within 48 hours of intravenous streptokinase therapy, to assess the prognosis of myocardial infarction (MI) secondary to thrombolytic therapy, and find if the reperfusion arrhythmias are non-invasive markers of successful thrombolysis using the electrocardiogram.

METHODOLOGY

100 Patients admitted to NRI Institute of Medical Sciences, Sangivalsa, tertiary care, teaching hospital in South India, with features suggestive of acute myocardial infarction who have undergone thrombolytic therapy are selected for the study. These 100 patients were divided into 5 age groups as 35-45,46-55, 56-65,66-75 and 76-85years. Each age group was further divided into male and female groups. Adult patients of both sexes and different age groups after obtaining formal consent from the patients or relatives were included. Reperfusion arrhythmias during and within 48 hours of thrombolytic therapy using electrocardiography (ECG) were assessed.

 

Inclusion Criteria

  1. Age more than 18 years
  2. Patients with documented MI based on two of the following criteria:
  3. Patients in whom a clinical diagnosis of MI was made based upon typical signs and symptoms, previous history of ischemic heart disease.
  4. ECG findings suggesting STEMI (ST-segment elevation myocardial infarction)

 

Exclusion Criteria

Patients with Congenital Heart Disease.

 

Statistical Analysis

Data were entered in MS Excel and analysed in SPSS V22. Descriptive statistics were done. The Chi-square test and ANOVA test were applied to find significance when needed. P ≤ 0.05 was considered statistically significant

RESULT

Among all types of myocardial infractions (MI), Reperfusion Arrhythmias are more prevalent in anterior wall MI (43%) and less observed in inferoposterior wall MI (7%), (Table1). The prevalence of the age and sex has been depicted in Graph 1 and 2 respectively. Maximum incidence of reperfusion arrhythmias was present in age group of 46-55 years i.e 28% followed by 66-75 i.e 26%,56-65-16%,35-45 and 76-85-15%. Among males and females, 57% of males and 43% of females showed maximum incidence. Results from Tables 2 and 3 showed that there was no significant relationship between age and gender with reperfusion arrhythmias.

 

Diagnosis

Reperfusion Arrhythmias

 

Total

No

Yes

 

 

Count

%

Count

%

Count

%

ALWMI

8

13.6%

6

14.6%

14

14.0 %

AN IF MI

3

5.1%

2

4.9%

5

5.0 %

AN INF MI

4

6.8%

3

7.3%

7

7.0 %

AWMI

24

40.7%

19

46.3%

43

43.0 %

IN PO MI

5

8.5%

1

2.4%

6

6.0 %

IN POST MI

0

0.0%

1

2.4%

1

1.0 %

IWMI

15

25.4%

9

22.0%

24

24.0 %

Total

59

100.0%

41

100.0%

100

100.0 %

Table 1: Relation of Reperfusion Arrhythmias with Type of Myocardial Infarction (MI) in Study Group

Chi-square value = 3.24; df= 6; P=0.778

 

 

 

Age

Reperfusion Arrhythmias

 

Total

No

Yes

 

 

Count

%

Count

%

Count

%

35-45

11

18.6%

4

9.8%

15

15.0 %

46-55

16

27.1%

12

29.3%

28

28.0 %

56-65

10

16.9%

6

14.6%

16

16.0 %

66-75

14

23.7%

12

29.3%

26

26.0 %

76-85

8

13.6%

7

17.1%

15

15.0 %

Total

59

100.0%

41

100.0%

100

100.0 %

Table 2: Relation of Reperfusion Arrhythmias with Age Groups in Study Group

Chi-square value = 1.88; df=4 ; P=0.758

 

Sex

Reperfusion Arrhythmias

 

Total

No

Yes

 

 

Count

%

Count

%

Count

%

Female

25

42.4%

18

43.9%

43

43.0 %

Male

34

57.6%

23

56.1%

57

57.0 %

Total

59

100.0%

41

100.0%

100

100.0 %

Table 3: Relation of Reperfusion Arrhythmias with Sex Groups in Study Group

Chi-square value = 0.023; df= 1; P=0.879

 

There was a significant relationship observed between reperfusion arrhythmias and Diabetes (p=0.023). Incidence with hypertension (HTN) was 53%, and although hypertension was high in MI, the p-value was not significant between reperfusion arrhythmias and hypertension. Reperfusion arrhythmias incidence in risk factors such as alcoholics and smokers which was not significant, suggests that there was no statistical significance between these risk factors and arrhythmias (Graph 3).

 

 

Observations drawn from results suggest that window period hospital presentation and types of myocardial infarction do not influence the occurrence of reperfusion arrhythmias (P=0.778) and there was a significant relation between reperfusion arrhythmias and survival of the effected patients of the study group  (p=0.014) which is shown in Table 4.

 

Outcome

Reperfusion Arrhythmias

 

Total

No

Yes

 

 

Count

%

Count

%

Count

%

Expired

0

0.0%

4

9.8%

4

4.0 %

Survived

59

100.0%

37

90.2%

96

96.0 %

Total

59

100.0%

41

100.0%

100

100.0 %

Table 4:  Relation of Reperfusion Arrhythmias to Outcome in Study Group

Chi-square value = 5.99; df= 1; P= 0.014

 

DISCUSSION

Arrhythmias and conduction disturbances are common during the early hours after an acute MI and a major cause of death in the pre-hospital phase. Their occurrence at the greatest frequency before or during thrombolysis indicates ongoing myocardial ischemia and reperfusion injury. STEMI is treated during the early window period of 8hrs with streptokinase or primary percutaneous intervention. Early thrombolysis is associated with a good prognosis in Acute MI. According to various studies and literature reperfusion arrhythmias during and within 48 hours of thrombolysis are associated with a good prognosis as well.

 

The term, reperfusion arrhythmias, was used in the first studies of thrombolytic therapy-guided revascularization in acute myocardial infarction. To confirm the presence of vessel patency and successful reperfusion of the myocardium following thrombolytic therapy, electrocardiographic data in addition to clinical and laboratory measures are used by the clinicians. These include normalization or more than 50% regression of ST elevation, T-wave inversion, and any other arrhythmia observed in electrocardiography. The most frequently observed arrhythmias that are defined as reperfusion arrhythmias are ventricular premature contractions, sustained or no sustained episodes of ventricular tachycardia, accelerated idioventricular rhythm, atrial fibrillation, and ventricular fibrillation. These arrhythmias are thought to be indicators of successful reperfusion.

 

According to Jurkovicova O, Cagan S13 reperfusion arrhythmias originate as a consequence of the complex cellular and humoral reactions accompanying the opening of the coronary artery. As the primary cause of their generation is considered the chemically defined substances that are produced and accumulated in the myocardium during reperfusion. The key role is ascribed to free oxygen radicals but of importance are also other substances such as calcium, thrombin, platelet-activating factor, inositol triphosphate, angiotensin II and others. These chemical mediators of reperfusion arrhythmias operate as modulators of cellular electrophysiology causing the complex changes at the level of ion channels. It is supposed that in the genesis of reperfusion arrhythmias unlike ischemic arrhythmias operate non-re-entrant mechanisms such as abnormal or enhanced automaticity and triggered activity due to depolarizations. As a typical reperfusion arrhythmia is considered an early (within 6 hours after the start of thrombolysis), frequent (> 30 episodes/hour), and repetitive (occurring during > 3 consecutive hours) Accelerated Idioventricular Rhythm (AIVR). AIVR with such characteristics has a high specificity and positive predictive accuracy but relatively low sensitivity as a predictor of reperfusion.

 

However, Gore et al.and14, Hacket et al15 do not find AIVR to be associated with successful reperfusion indicating ventricular rhythm may be a marker of early reperfusion and continuing arterial patency. In a previous study, the presence of accelerated idioventricular rhythm combined with normalization of ST segments was demonstrated to indicate successful reperfusion in patients treated with thrombolytics and there was no requirement for emergency coronary angiography and rescue percutaneous coronary intervention (PCI) in this group of patients. Among these, AIVR was the most sensitive and specific arrhythmia in cases of successful reperfusion.

 

Various types of arrhythmias were observed in the present study, AIVR is the most common type of reperfusion arrhythmias, 13% of patients developed this. This was a similar observation as seen in the studies done by Ersan Tatli et al16 (73.3%), and Terkelsen et al17 (42%) except the percentage was low in our study (13%). Chiladakis et al18 observed the presence of AIVR combined with normalization of ST segments, indicating successful reperfusion in patients treated with thrombolytics.

 

This study consists of 5 different groups of ST-segment elevation MI (STEMI) are anterior wall MI (AWMI)-43%, inferior wall MI (IWMI)-24%, anterolateral wall MI (ALWMI)-14%, anteroinferior wall MI (AN INF MI)-12%, inferoposterior wall MI (IN PO MI)-7% when compared to study done by Sarala. H. Tippannavar19 in which most of the patients (83%) had ST-segment elevation MI of which 34% had extensive anterior wall MI, 23% had inferior wall MI, 14% had anteroseptal wall MI, 6% had an inferior wall with Right ventricular (RV) extension, 3% had lateral and anterolateral wall MI each, and non-ST elevation MI patients were 17%.

 

This study was done to show the prevalence of reperfusion arrhythmias in STEMI during and within 48hrs of streptokinase therapy in different age and sex groups. Maximum incidence of acute STEMI was seen between 45-75 years 70% of them were in the 46-55years age group. Similarly, in a study done by MartinTC et al20, an incidence of 85% between 35-75 years of age was reported. Age incidence is probably more common because of lifestyle, economic status, multiple risk factors, and life expectancy.

 

In this study, 57 % of males and 43% of females showed arrhythmias similar to the study done by Martin TC et al20, where incidence was 72% in males and 28% in females, and by Kock HL et al21 where 72% were males and 24% were females. It is more common among males because of lifestyle and more risk factors like hypertension, smoking, diabetes mellitus, and alcohol.

 

It was observed in this study that 70% of the patients presented with chest pain, 15 % with shortness of breath (SOB), and 15% with both. It is compared to a study conducted by Mhatre MA et al.22 where the pattern and incidence of various symptoms of acute MI among which chest pain was the most common presenting symptom observed in 80% of patients and 15% of them had altogether epigastric pain and pain in left arm alone. Sweating was 2nd most common symptom (64%) followed by dyspnea (43%), Vomiting (28%), palpitation (11%), and giddiness /syncope (8%).

 

Risk factors like type 2 diabetes mellitus(DM) had an incidence of 38% in the present study as compared to 19% in Svensson AM et al23 study. It shows a higher incidence of type 2 diabetes mellitus in acute MI patients, indicating DM is a major risk factor. 53% had hypertension showing a higher prevalence of acute MI in disease groups which is in agreement with Kokubo Y et al24 study. This study has similar observations regarding DM and hypertension as seen in a study by Yavagal et al25 and in contrary to the study by Chatterjee et al.26 According to Ambrose and Barua et al27, cigarette smoke exposure is an important cause of cardiovascular morbidity and mortality. In this study 38% are associated with alcohol, however, several studies show that mild alcohol consumption has a protective role in acute coronary syndrome (ACS), whereas large amounts and binge intake are associated with acute MI.  The role of alcohol as a risk factor is still controversial.

 

The following arrhythmias are regarded also as markers of reperfusion: frequent premature ventricular complexes (twofold increase in frequency within 90 minutes after the start of thrombolysis), a significant increase of episodes in nonsustained ventricular tachycardia, sinus bradycardia and probably also high-degree atrioventricular blocks, other probable arrhythmias include sinus tachycardia and ventricular fibrillation (VF). Thus, reperfusion arrhythmias are an important non-invasive marker of successful recanalization of the infarction-related coronary artery.

 

Sinus bradycardia (SB) was most associated with inferior wall myocardial infarction. In the present study, 3% had sinus bradycardia, out of which 2% were of inferior wall myocardial infarction (Graph 4). In all these patients, sinus bradycardia was transient, and majority of the patients had normal sinus rhythm (NSR) by the end of the first day. Similar observations were made by Swart G et al28, whereas in the study conducted by Michel Rotman et al29 10-30%, in Philip J Podrid30 study 16% to 25% of patients had sinus bradycardia, particularly of inferior wall MI and posterior wall MI. It was most often transient. Brady-arrhythmias and hypotension are common in proximal occlusion of the right coronary artery commonly leading to inferior myocardial infarction, because of reflexes arising from the ischemic right ventricle.

 

Sinus tachycardia was present only in 10%. This is mostly seen in AWMI-6% and IWMI-3%, as compared to Sarala. H. Tippannavar19 study. Where the incidence is 22%, it was so low in this study. There was no mortality in the present study group, which was contrary to Crimm A et al31, where the mortality incidence was 23.72%, in reference that sinus tachycardia is associated with adverse outcomes.

 

In the present study, there were no deaths in patients with SB and inferior wall MI, indicating a protective role of SB in inferior wall MI. Similar observations were made by Malla RR and Sayani A32. Occasionally they may progress to complete heart block so treatment with atropine and intravenous fluids and inotropes may be needed and in severe conditions may also need pacemaker implantation.

 

Overall, 15% of Ventricular arrhythmias are seen in present subjects, that is Ventricular fibrillation (VF) 1%, Ventricular Tachycardia (VT) 3%, Ventricular Premature Complexes (VPC) 11%, when compared to Henkel DM, Wltt BJ et al33 studies, where the incidence was low. In Ravi Kumar Navsk study34 Ventricular arrhythmias were present in 32% of them of which 24% had Ventricular Tachycardia (VT) and 28% had Ventricular Premature Beats (VPB). In Sarala. H. Tippannavar et al19 Ventricular arrhythmias were seen in 31 cases of which VPBs in 23 cases, VT in 6 cases, and VF in 2 cases. Mhatre MA et al22 show the overall incidence of ventricular arrhythmias being 33% of which VT was 24%, VPC was 8% and ventricular bigeminy was 1%, also overall incidence is more in anterior and lateral wall MI than inferior wall alone.

 

In this study, VPC’s are present in 11% population Which was of low incidence compared to Mohit J Shah et al35 study, in which VPCs were observed in 31% of the patients when they occurred alone. There is no mortality in VPC s in this study group, which indicates VPC has a good prognostic significance.

 

The incidence of VT in this study is 3%, 2% in AWMI, and 1% in AN IF MI contrary to a study done by Horvat D et al36 where VT was seen more in anterolateral MI than anteroseptal MI. In another study by Gibson et al37 exhibited the development of VT and VF in 3491 patients with STEMI after thrombolytic therapy. Mortality seen in patients with VT was 100% In the present study, whereas the study done by Metal GC and Al-Khatib S38 was 25.2% and 24% respectively. This discrepancy could be explained by larger infarcts and older age in the present study.

 

This study shows total mortality of 4% i.e. associated with VT/VF as compared with the study by Newby KH et al39 showed that sustained VT and VF occur in up to 20% of patients with AMI and have been associated with poor prognosis. It is a fact that primary VF, irrespective of timing, is an independent predictor of in-hospital mortality. In the study by Behar S et al40, the incidence of secondary VF complicating acute MI was 2.4% whereas a study done by Trappolini M et al41 shows 24.4% mortality, and a study by Simon T et al42 showed 25% mortality in females. This difference in mortality in this study may be explained by associated complications in present cases. In the current study, mortality is common in anterior wall MI and anteroinferior wall MI, as compared to Mohit J Shah et al35 mortality is high in anterior wall MI as compared to inferior wall MI.

 

Thus, RA is not an event of serious concern as they are usually well-tolerated and are amenable to treatment. They indicate effective reperfusion when present. Early streptokinase therapy has a favorable impact on mortality in MI and hence should be tried in all the Acute MI patients who do not have contraindications for streptokinase therapy.

CONCLUSION
  • Arrhythmias are most frequently seen during or following thrombolysis of Acute MI. Mortality and morbidity of Acute MI can be modified by early recognition and management of these arrhythmias.
  • In this study modifiable risk factors like diabetes, hypertension, smoking, and alcohol are associated with Acute MI. these can be managed by proper public health education and regular medication.
  • Acute MI is a major cause of hospitalization in the elderly and is associated with higher mortality and morbidity, most frequently seen between the 4th to 7th decades, with male preponderance.
  • Acute MI is commonly associated with the Anterior wall, with a higher incidence of reperfusion arrhythmias being Accelerated Idioventricular Rhythm (AIVR).
  • Mortality was high in Anterior wall MI, Ant Inf wall MI, which were associated with Ventricular Tachycardia, Ventricular Fibrillation, showing 100% mortality which must be intervened immediately.
  • Reperfusion Arrhythmias are not an event of serious concern as they are usually well-tolerated and are amenable to treatment. Early streptokinase therapy has a favorable impact on mortality in MI and hence should be tried in all the Acute MI patients who do not have contraindications for streptokinase therapy
REFERENCES
  1. Robin NM, Bramah SN. Arrhythmias in acute myocardial infarction. In: Norris RM edt: Myocardial infraction – its presentation, pathogenesis, and treatment. 1st Part-1, New York: Churchill Livingstone 1982:55-63.
  2. Berger P, Ryan T, Inferior myocardial infraction. Circulation 1990;81:401-11.
  3. Majumder AA, Malik A, Zafar A. Conduction disturbances in acute myocardial infarction: incidence, site-wise relationship and the influence on in-hospital prognosis. Bangladesh Medical Research Council Bulletin 1996;22(2):74-80.
  4. Antman EM, Loscalzo J. Ischemic heart disease. Harrison’s principles of internalmedicine.19th edn, Chap- 293, USA: McGraw-Hill Companies 2015:1578-9.
  5. Daivadanam M. Pathways to catastrophic health expenditure for acute coronary syndrome in Kerala: ‘Good health at low cost’? BMC Public Health 2012;12(1):306.
  6. Daivadanam M, Thankappan KR, Sarma PS, et al. Catastrophic health expenditure & coping strategies associated with acute coronary syndrome in Kerala, India. The Indian Journal of Medical Research 2012;136(4):585.
  7. Ohira T, Iso H. Cardiovascular disease epidemiology in Asia. Circulation Journal 2013;77(7):1646-52.
  8. Huo Y, Thompson P, Buddhari W, et al. Challenges and solutions in medically managed ACS in the Asia-Pacific region: expert recommendations from the Asia-Pacific ACS Medical Management Working Group. International Journal of Cardiology 2015;183:63-75.
  9. Vedanthan R, Seligman B, Fuster V. Global perspective on acute coronary syndrome. Circulation Research 2014;114(12):1959-75.
  10. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. European Heart Journal 2012;33(20):2551-67.
  11. Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics-2016 update. Circulation 2016;133(4):e38-60.
  12. Murray CJ, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015;386: 2145-91.
  13. Jurkovicová O, Cagán S. Bratisl Lek Listy. Review Slovak 1998;99(3-4):162-71.
  14. Gore JM, Ball SP, Corrao JM, Goldberg RJ. Arrhythmias in the assessment of coronary artery reperfusion following thrombolytic therapy. Chest 1988;94(4):727-30.
  15. Hackett D, McKenna W, Davies G, Maseri A, Lowe T, Aber V. Reperfusion arrhythmias are rare during acute myocardial infarction and thrombolysis in man. International Journal of Cardiology 1990;29(2):205-13.
  16. Tatli E, Alicik G, Buturak A, et al. Arrhythmias following Revascularization Procedures in the Course of Acute Myocardial Infarction: Are They Indicators of Reperfusion or Ongoing Ischemia? The Scientific World Journal 2013; Article ID 160380, 7 pages.
  17. Terkelsen CJ, Sørensen JT, Kaltoft AK, et al. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. The American Journal of Cardiology 2009;104(12):1641-6.
  18. Chiladakis JA, Vlachos N, Patsouras N, et al. Usefulness of reperfusion ventricular arrhythmias in non-invasive prediction of early reperfusion and sustained coronary artery patency in acute myocardial infarction. Journal of Thrombosis and Thrombolysis 2001;12(3):231-6.
  19. Tippannavar SH, Shekhanawar MS, Gunasheelan N. The study of arrhythmias following myocardial infarction occurring within one week. Journal of Evolution of Medical and Dental Sciences 2012;1(6).
  20. Martin TC, Van Longhuyzen H, Bennett B, et al. The age-specific incidence of admission to the intensive care unit for acute myocardial infarction in Antigua and Barbuda. West Indian Medical Journal 2007;56(4):326-9.
  21. Koek HL, De Bruin A, Gast A, et al. Incidence of first acute myocardial infarction in the Netherlands. Neth J Med 2007;65(11):434-41.
  22. Mhatre MA, Sirur FM, Rajpal DR, et al. A clinical study of arrhythmias associated with acute myocardial infarction and thrombolysis. International Journal of Research in Medical Sciences 2016;5(1):335-43.
  23. Svensson AM, Dellborg M, Abrahamsson P, et al. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries. International Journal of Cardiology 2007;119(3):319-25.
  24. Kokubo Y, Kamide K, Okamura T, et al. Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease in a Japanese Urban Cohort. Hypertension 2008;52(4):652-9.
  25. Yavagal ST, Rangarajan R, Prabhavathi. Clinical profile of acute myocardial infarction in women. JIMA 1993;92(9):283-4.
  26. Chatterjee SS, Banerjee A, Dutta S, et al. Risk factors of myocardial infarction in Indian women. Indian Heart Journal 1987;39(6):57.
  27. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American College of Cardiology 2004;43(10):1731-7.
  28. Swart G, Brady WJ, DeBehnke DJ, et al. Acute myocardial infarction complicated by hemodynamically unstable bradyarrhythmia: prehospital and ED treatment with atropine. The American Journal of Emergency Medicine 1999;17(7):647-52.
  29. Rotman M, Wagner GS, Wallace AG. Bradyarrhythmias in acute myocardial infarction. Circulation 1972;45(3):703-22.
  30. Podrid PJ. Arrthymias after acute myocardial infarction. Postgraduate Medicine 1997;102(5):679-88.
  31. Crimm A, Severance HW, Coffey K, et al. Prognostic significance of isolated sinus tachycardia during first three days of acute myocardial infarction. The American Journal of Medicine 1984;76(6):983-8.
  32. Malla RR, Sayami A. In hospital complications and mortality of patients of inferior wall myocardial infarction with right ventricular infarction. JNMA J Nepal Med Assoc 2007;46(167):99-102.
  33. Henkel DM, Witt BJ, Gersh BJ, et al. Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. American Heart Journal 2006;151(4):806-12.
  34. Navsk RK, Madhusudhana Babu M, et al. Association of arrhythmias with acute myocardial infarction in the Peri-Infarction Period: A Prospective Study. Journal of Evolution of Medical and Dental Sciences 2015;4(71):12316-21.
  35. Shah MJ, Bhatt NR, Dabhi A, et al. A study of 100 cases of arrhythmias in the first week of acute myocardial infarction (AMI) in Gujarat: a high risk and previously undocumented population. Journal of Clinical and Diagnostic Research: JCDR 2014;8(1):58.
  36. Horvat D, Grman-Fanfani A, Kupres V, et al. Frequency of ventricular premature beats and ventricular tachycardia in STEMI treated with fibrinolytics. Collegium Antropologicum 2008;32(1):99-102.
  37. Gibson CM, Pride YB, Buros JL, et al. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 2008;51(5):546-51.
  38. Al-Khatib SM, Stebbins AL, Califf RM, et al. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. American heart journal. 2003;145(3):515-21.
  39. Newby KH, Thompson T, Stebbins A, et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy. Circulation 1998;98(23):2567-73.
  40. Behar S, Reicher-Reiss H, Shechter M, et al. Frequency and prognostic significance of secondary ventricular fibrillation complicating acute myocardial infarction. The American Journal of Cardiology 1993;71(2):152-6.
  41. Trappolini M, Chillotti FM, Rinaldi R, et al. Sex differences in incidence of mortality after acute myocardial infarction. Italian heart journal. Supplement: official journal of the Italian Federation of Cardiology 2002;3(7):759-66.
  42. Puymirat E, Simon T, Steg PG, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA 2012;308(10):998-1006.
Recommended Articles
Research Article
Patterns The study of nutrient foramina in human clavicle
Published: 05/02/2025
Download PDF
Research Article
Fixation of pertrochanteric fracture with proximal femoral nail in adults
Published: 20/09/2018
Download PDF
Research Article
Predictive Value of Serum Uric Acid in Patients with Decompensated Chronic Heart Failure at Tertiary Care Teaching Hospital
Published: 28/12/2016
Download PDF
Research Article
Comparative Study of Dexmedetomidine and Propofol for Sedation in Pediatric Patients Undergoing MRI Scans.
Published: 25/04/2017
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.